|
Kenneth S. Suslick (born 1952) is the ''Marvin T. Schmidt'' Professor of Chemistry, Professor of Materials Science & Engineering, and Professor of the Beckman Institute for Advanced Science & Engineering at the University of Illinois at Urbana-Champaign. He is the world’s leading expert on the chemical and physical effects of ultrasound〔Xu, H.; Zeiger, B. W.; Suslick, K. S. "Sonochemical synthesis of nanomaterials" Chem. Soc. Rev. 2013, 42, 2555-2567. (DOI: 10.1039/c2cs35282f. )〕 and has received numerous awards for his work on sonochemistry and sonoluminescence. Professor Suslick has also introduced new technology in chemical sensing, specifically the use of colorimetric sensor arrays as an optoelectronic nose.〔(Nature 406, 710-713 (17 August 2000) | doi:10.1038/35021028 )〕 ==Career== Ken Suslick received his B.S. from the California Institute of Technology in 1974, his Ph.D. from Stanford University in 1978, and came to the University of Illinois at Urbana-Champaign immediately thereafter. He was promoted to full professor at the age of 35, held the first ''William H. & Janet Lycan'' Professorship in Chemistry, and then in 2004 became the inaugural ''Marvin T. Schmidt'' Professor of Chemistry at the University of Illinois.〔(Suslick curriculum vitae )〕 Professor Suslick is a Fellow of the American Chemical Society, the Royal Society of Chemistry, the Materials Research Society, the Acoustical Society of America, and the American Association for the Advancement of Science. Professor Suslick has mentored more than (61 Ph.D. students and 32 postdoctoral associates. ) He has published more than (350 scientific papers, edited four books, and holds more than 20 patents. ) His papers have been cited more than 30,000 times and his h-index is 88 (i.e., 88 papers with 88 or more citations), (as of November, 2014. ) His six most cited papers are listed below.〔“Sonochemistry” Science 1990, 247, 1439;〕〔"Sonochemical Synthesis of Amorphous Iron” Nature 1991, 353, 414;〕〔“The Sonochemical Hot Spot” J. Am. Chem. Soc. 1986, 108, 5641;〕〔"Applications of Ultrasound to Materials Chemistry” Annu. Rev. Matl. Sci., 1999, 29, 295;〕〔“The Temperature of Cavitation” Science 1991, 253, 1397;〕〔"A colorimetric sensor array for odour visualization," (Nature 406, 710-713 (17 August 2000) | doi:10.1038/35021028 )〕 In addition to his academic research, Professor Suslick has had significant entrepreneurial experience. He was the lead consultant for Molecular Biosystems Inc. and part of the team that commercialized the first echo contrast agent for medical sonography, Albunex™,〔(MBI's Albunex FDA approval )〕 which became Optison™ by GE Healthcare. In addition, he was the founding consultant for VivoRx Pharmaceuticals and helped invent and commercialize Abraxane™, albumin microspheres with a paclitaxel core, which is the predominant current delivery system for taxol chemotherapy for breast cancer; VivoRx became (Abraxis Bioscience, which was acquired by Celgene for $2.9 billion. ) He then co-founded ChemSensing and its successor, (iSense Systems/Metabolomx ) in Mountain View, for the commercialization of the Suslick group's optoelectronic nose technology with particular focus on biomedical applications of this unique sensor technology. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Kenneth S. Suslick」の詳細全文を読む スポンサード リンク
|